跳至主導覽 跳至搜尋 跳過主要內容

Identifying heterogeneous subgroups of systemic autoimmune diseases by applying a joint dimension reduction and clustering approach to immunomarkers

  • Chia Wei Chang
  • , Hsin Yao Wang
  • , Wan Ying Lin
  • , Yu Chiang Wang
  • , Wei Lin Lo
  • , Ting Wei Lin
  • , Jia Ruei Yu
  • , Yi Ju Tseng*
  • *此作品的通信作者
  • National Yang Ming Chiao Tung University
  • Chang Gung Memorial Hospital
  • National Tsing Hua University
  • Syu Kang Sport Clinic
  • Brigham and Women’s Hospital
  • University of California at San Diego
  • University of Hawai'i at Mānoa
  • Queen's Medical Center Hawaii
  • Boston Children's Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

3 引文 斯高帕斯(Scopus)

摘要

Background: The high complexity of systemic autoimmune diseases (SADs) has hindered precise management. This study aims to investigate heterogeneity in SADs. Methods: We applied a joint cluster analysis, which jointed multiple correspondence analysis and k-means, to immunomarkers and measured the heterogeneity of clusters by examining differences in immunomarkers and clinical manifestations. The electronic health records of patients who received an antinuclear antibody test and were diagnosed with SADs, namely systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjögren’s syndrome (SS), were retrieved between 2001 and 2016 from hospitals in Taiwan. Results: With distinctive patterns of immunomarkers, a total of 11,923 patients with the three SADs were grouped into six clusters. None of the clusters was composed only of a single SAD, and these clusters demonstrated considerable differences in clinical manifestation. Both patients with SLE and SS had a more dispersed distribution in the six clusters. Among patients with SLE, the occurrence of renal compromise was higher in Clusters 3 and 6 (52% and 51%) than in the other clusters (p < 0.001). Cluster 3 also had a high proportion of patients with discoid lupus (60%) than did Cluster 6 (39%; p < 0.001). Patients with SS in Cluster 3 were the most distinctive because of the high occurrence of immunity disorders (63%) and other and unspecified benign neoplasm (58%) with statistical significance compared with the other clusters (all p < 0.05). Conclusions: The immunomarker-driven clustering method could recognise more clinically relevant subgroups of the SADs and would provide a more precise diagnosis basis.

原文英語
文章編號36
頁(從 - 到)36
期刊BioData Mining
卷17
發行號1
DOIs
出版品狀態已出版 - 16 09 2024
對外發佈是

文獻附註

Publisher Copyright:
© The Author(s) 2024.

指紋

深入研究「Identifying heterogeneous subgroups of systemic autoimmune diseases by applying a joint dimension reduction and clustering approach to immunomarkers」主題。共同形成了獨特的指紋。

引用此